Skip to main content

Understanding the Part D spending dynamics of heart failure patients

26 July 2018

Part D spending by heart failure (HF) patients is higher than for other patients due to their condition and related comorbidities. Understanding pharmacy spending by HF patients requires an evaluation of the complex interactions between members, payers, manufacturers, and the government in Part D.

This report was commissioned by Novartis Pharmaceuticals Corporation.


About the Author(s)

Harsha Mirchandani

We’re here to help